ArticleClinical and translational radiation oncology2027
Acute breast edema during 5-fraction ultra-hypofractionated radiotherapy after breast-conserving surgery: A cone-beam CT based evaluation.
Article in Clinical and translational radiation oncology, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: With the growing adoption of 5-fraction ultra-hypofractionated radiotherapy (uHFRT) following breast-conserving surgery (BCS), in-treatment breast edema has been increasingly observed. Marked edema may impair target dose coverage and even necessitate radiotherapy interruption. This study aimed to investigate the incidence, evolution and risk factors of this acute adverse event. Methods: Patients treated with BCS were enrolled in a prospective phase II trial of uHFRT. Patients received whole-breast irradiation (WBI) at 26 Gy in 5 fractions, with or without simultaneous integrated tumor-bed boost (SIB) of 30 Gy, delivered daily or on alternate days. Cone-beam CT (CBCT) was acquired prior to each fraction. Acute breast edema was defined as outward expansion of the breast contour exceeding 1 mm relative to the planning CT. Clinical and target volume parameters were analyzed to identify risk factors. Results: Among 221 patients (224 breasts), edema occurred in 83 breasts (37.1%), with 96.4% developing after the first fraction. The prevalence of edema was 35.7%, 36.6%, 37.1%, and 35.3% at the 2nd to 5th pretreatment CBCT scans, respectively. Edema peaked after the first fraction in 42 swelling breasts (50.6%). Contour expansion was >3-5 mm in 19.6%, >5-8 mm in 7.1%, >8-10 mm in 1.8%, and > 10 mm in 0.9% of all breasts. Multivariate analysis indentified younger age and greater breast thickness as significant factors associated with the occurrence of in-treatment breast edema. Furthermore, breast thickness was positively associated with edema severity. Conclusions: The incidence of acute in-treatment breast edema during uHFRT after BCS was 37.1%, with onset immediately after the first fraction in 96.4% of affected cases. Contour expansion >5 mm was observed in 9.8% of the entire cohort. Given the short treatment course and high single-fraction dose, early-onset edema may impair treatment efficacy. Close surveillance and timely intervention are warranted for high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.